A latest research was published in the Lancet Neurology and it suggested that there was a bright possibility in near future to treat Parkinson's disease with the help of gene therapy.

Using a virus to add genes into brain cells, the US researchers were successful in reducing the symptoms for half of the patients.

Raising the concerns over soaring number of patients of this disease, this report suggests that around 120,000 people are suffering from this deadly disease in UK.

Parkinson's UK perceives the findings of this study as a breakthrough but it opines that more advanced research was needed to reach to substantial conclusions.

This disease could cause uncontrolled shaking, stiffness and slow movement as a part of the brain dies and the most disappointing thing is that there is no treatment available for it but some drugs and deep brain stimulation have been proving quite effective to reduce its symptoms.

Professor Nicholas Mazarakis, who is a specialist in gene therapy at Imperial College London, said, “This result should be taken with some caution though, as it constitutes a rather small mean improvement, only 10.4%, in the clinical rating scale motor scores between those patients receiving the gene therapy and the placebo group”.

Being uncertain about the longevity of the benefits of this treatment, Dr. Michelle Gardner, Research Development Manager at Parkinson's UK, confirmed the need for advanced research on this topic.